|
The crucial role of high C-reactive protein interval and Glasgow prognostic score for predicting prognosis in esophageal cancer patients undergoing chemoradiotherapy
|
N. Gurdal   , H. Akboru , S. Dincer , H.I. Acan , B.A. Yildirim , N. Yasar , G. Kulduk , P.O. Nayir , F. Saglam , A. Alemdar , H. Guven |
| University of Health Sciences, Prof Dr Cemil Tascioglu City Hospital, Department of Radiation Oncology,Istanbul,Turkey , gurdalnecla@hotmail.com |
|
|
Abstract: (1250 Views) |
Background: Our aim was to draw attention to the dominant role of C-reactive protein (CRP) on prognosis by examining the effect of the high CRP interval, Glasgow Prognostic Score (GPS), modified Glasgow Prognostic Score (mGPS) and CAR (CRP to albumin ratio) in patients undergoing chemoradiotherapy (CRT). Materials and Methods: 85 patients, with the diagnosis of esophageal cancer and who were scheduled for neoadjuvant or definitive CRT, were included in the study. CRP levels of each patient during the follow-up period were determined separately, and the total number of days for which serum CRP levels were > 5 mg/L was expressed as "days when CRP>5". The effects of the GPS, mGPS, CAR, and‘’days when CRP>5’’ on the prognosis and survival of these patients with esophageal cancer were analyzed in this retrospective study. Results: In the survival analysis, CAR (p=0.007), GPS (p<0.001), mGPS (p<0.001) and ‘’days when CRP > 5’’ (p=0.002) were determined to be independent predictive factors for mortality. In the long-rank test results, it was observed that the patients with GPS 0 and mGPS 0 had longer overall survival than the others (p < 0.001). In addition, with the increase in ‘’days when CRP>5’’, disease recurrence also increased significantly (p = 0.01). Similarly, in the ROC analysis, the area under the curve (AUC) was significant for the ‘’days when CRP>5’’ (AUC: 0.956, 95% CI: 0.915‒0.998; P < 0.001). Conclusions: In patients diagnosed with esophageal cancer, beginning from the pretreatment period and throughout the follow-up period, serum CRP levels are an independent factor in predicting survival, both in terms of the number of days it is high and in terms of the scoring systems it is associated with. |
|
| Keywords: C-reactive protein, High CRP Interval, Glasgow prognostic score, esophagus cancer. |
|
|
Full-Text [PDF 540 kb]
(672 Downloads)
|
|
Type of Study: Original Research |
Subject:
Radiation Biology
|
|
|
|
|
|
|
| References |
1. van Hagen P, Hulshof MC, van Lanschot JJ, et al. (2012) CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med, 366(22): 2074-84. [ DOI:10.1056/NEJMoa1112088] [ PMID] 2. Torre LA, Bray F, Siegel RL, et al. (2015) Global cancer statistics, 2012. CA Cancer J Clin, 65(2): 87-108. [ DOI:10.3322/caac.21262] [ PMID] 3. Forrest LM, McMillan DC, McArdle CS, et al. (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer, 89(6): 1028-30. [ DOI:10.1038/sj.bjc.6601242] [ PMID] [ ] 4. Numata K, Ono Y, Toda S, et al. (2020) Modified Glasgow prognostic score and carcinoembryonic antigen predict poor prognosis in elderly patients with colorectal cancer. Oncol Res Treat, 43(4): 125-133. [ DOI:10.1159/000505930] [ PMID] 5. Lu X, Guo W, Xu W, et al. (2018) Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients. Cancer Manag Res, 11: 229-249. [ DOI:10.2147/CMAR.S185350] [ PMID] [ ] 6. Petrelli F, Barni S, Coinu A, et al. (2015) The modified Glasgow prognostic score and survival in colorectal cancer: A pooled analysis of the literature. Rev Recent Clin Trials, 10(2): 135-41. [ DOI:10.2174/1574887110666150317121413] [ PMID] 7. Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: Pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr, 43(2): 181-193. [ DOI:10.1002/jpen.1451] [ PMID] [ ] 8. Tong T, Guan Y, Xiong H, et al. (2020) A meta-analysis of glasgow prognostic score and modified Glasgow prognostic score as biomarkers for predicting survival outcome in renal cell carcinoma. Front Oncol, 10: 1541. [ DOI:10.3389/fonc.2020.01541] [ PMID] [ ] 9. Chen P, Fang M, Wan Q, et al. (2017) High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy. Oncotarget, 8(59): 99861-99870. [ DOI:10.18632/oncotarget.21734] [ PMID] [ ] 10. Urabe M, Yamashita H, Watanabe T, Seto Y (2018) Comparison of prognostic abilities among preoperative laboratory data ındices in patients with resectable gastric and esophagogastric junction adenocarcinoma. World J Surg, 42(1): 185-194. [ DOI:10.1007/s00268-017-4146-9] [ PMID] 11. Sakai M, Sohda M, Saito H, et al. (2020) Comparative analysis of ımmunoinflammatory and nutritional measures in surgically resected esophageal cancer: A single-center retrospective study. In-Vivo, 34(2): 881-887. [ DOI:10.21873/invivo.11853] [ PMID] [ ] 12. Ju SY and Ma SJ (2020) High C-reactive protein to albumin ratio and the short-term survival prognosis within 30 days in terminal cancer patients receiving palliative care in a hospital setting: A retrospective analysis. Medicine (Baltimore), 99(9): e19350. [ DOI:10.1097/MD.0000000000019350] [ PMID] [ ] 13. Amano K, Maeda I, Morita T, et al. (2016). Clinical ımplications of C-reactive protein as a prognostic marker in advanced cancer patients in palliative care settings. J Pain Symptom Manage, 51(5): 860-7. [ DOI:10.1016/j.jpainsymman.2015.11.025] [ PMID] 14. Wei XL, Wang FH, Zhang DS, et al. (2015) A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-Reactive protein/albumin ratio. BMC Cancer, 15: 350. [ DOI:10.1186/s12885-015-1379-6] [ PMID] [ ] 15. Wang Y, Li P, Li J, et al. (2019) The prognostic value of pretreatment Glasgow prognostic score in patients with esophageal cancer: A meta-analysis. Cancer Manag Res, 11: 8181-8190. [ DOI:10.2147/CMAR.S203425] [ PMID] [ ] 16. McMillan DC, Crozier JE, Canna K, et al. (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis, 22(8): 881-6. [ DOI:10.1007/s00384-006-0259-6] [ PMID] 17. Ibuki Y, Hamai Y, Hihara J, et al. (2017) Role of postoperative C-Reactive protein levels in predicting prognosis after surgical treatment of esophageal cancer. World J Surg, 41(6): 1558-1565. [ DOI:10.1007/s00268-017-3900-3] [ PMID] 18. Cui X, Jia Z, Chen D, et al. (2020) The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis. Medicine (Baltimore), 99(14): e19165. [ DOI:10.1097/MD.0000000000019165] [ PMID] [ ] 19. Tong T, Guan Y, Xiong H, et al. (2020) A meta-analysis of Glasgow prognostic score and modified Glasgow prognostic score as biomarkers for predicting survival outcome in renal cell carcinoma. Front Oncol, 10: 1541. [ DOI:10.3389/fonc.2020.01541] [ PMID] [ ] 20. Wu D, Wang X, Shi G, et al. (2021) Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients. Aging (Albany NY), 13(1): 1410-1421. [ DOI:10.18632/aging.202357] [ PMID] [ ] 21. He L, Li H, Cai J, et al. (2018) Prognostic value of the Glasgow prognostic score or modified Glasgow prognostic score for patients with colorectal cancer receiving various treatments: A systematic review and meta-analysis. Cell Physiol Biochem, 51(3): 1237-1249. [ DOI:10.1159/000495500] [ PMID] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Gurdal N, Akboru H, Dincer S, Acan H, Yildirim B, Yasar N, et al . The crucial role of high C-reactive protein interval and Glasgow prognostic score for predicting prognosis in esophageal cancer patients undergoing chemoradiotherapy. Int J Radiat Res 2023; 21 (3) :485-489 URL: http://ijrr.com/article-1-4877-en.html
|
